Background
Elekta Limited is a medical technology company that holds U.S. Patent No. 7,295,648 covering methods and apparatus for treating patients with ionizing radiation — a technology used in radiosurgery and radiation therapy systems. ZAP Surgical Systems, Inc. challenged the patent in inter partes review (IPR). PTAB found the challenged claims obvious based on a combination of two prior art references: one describing a device used for imaging (the Grady device) and one describing a linear accelerator (linac) system used for radiation delivery (Ruchala).
Elekta appealed, arguing that a skilled artisan would not have been motivated to combine the references and would not have had a reasonable expectation of success in doing so. Elekta pointed out that the Grady device was an imaging tool, not a radiation device, and that the weight of the linac described in Ruchala would have made the Grady device physically inoperable as a mounting platform. PTAB had found motivation to combine and implicitly found reasonable expectation of success through its motivation analysis — without making a separate, explicit finding on expectation of success. Elekta contended this was legal error.
The Court’s Holding
The Federal Circuit affirmed the PTAB’s obviousness finding. On motivation to combine, the court found substantial evidence supporting PTAB’s determination that a skilled artisan would have been motivated to combine the prior art references to arrive at the claimed radiosurgery device, including that prosecution history of the patent itself acknowledged the known technique of mounting radiation devices in a way similar to the claimed system.
The more significant holding addressed reasonable expectation of success. The court clarified that, unlike a motivation-to-combine finding, a finding of reasonable expectation of success does not need to be stated as an explicit, separate finding in the Board’s opinion. In some cases — particularly where the evidence supporting motivation to combine is comprehensive and directly speaks to whether the proposed combination would work — the motivation-to-combine analysis can implicitly encompass and establish the reasonable expectation of success. The court reviewed the Board’s detailed analysis of the prior art and the challenges Elekta raised about the combination’s feasibility, found that the Board had addressed those feasibility concerns through its motivation analysis, and concluded that it could reasonably discern from the Board’s opinion that it had implicitly found a reasonable expectation of success.
Key Takeaways
- A reasonable expectation of success need not be stated as an explicit, separate finding in an obviousness analysis — it may be implicit in a thorough and well-supported motivation-to-combine analysis.
- When the evidence establishing motivation to combine also directly addresses the technical feasibility of the proposed combination, that evidence can simultaneously satisfy both the motivation and expectation-of-success requirements.
- Patent owners challenging PTAB obviousness findings should point to specific gaps in the Board’s analysis rather than arguing the conclusion should have been labeled more explicitly as a separate finding.
- Prosecution history can be used against a patent owner as evidence supporting motivation to combine — admissions made during prosecution about the state of the art are part of the intrinsic record.
Why It Matters
The decision provides helpful clarification for PTAB practitioners on how strictly courts will scrutinize the form of an obviousness analysis. Obviousness requires showing both motivation to combine and reasonable expectation of success as distinct legal elements. But the Federal Circuit’s ruling confirms that these elements can overlap in their evidentiary basis — a detailed motivation analysis that addresses technical feasibility may simultaneously satisfy both requirements without the Board needing to separately label and analyze each element in sequence.
For patent owners seeking to challenge IPR final written decisions, this decision signals that purely formal objections (“the Board didn’t explicitly say ‘reasonable expectation of success’”) are unlikely to succeed when the Board’s analysis as a whole addresses the relevant technical questions. For IPR petitioners, the decision provides confidence that thorough motivation-to-combine briefing — which directly addresses why the combination would work — can carry both elements of the obviousness analysis. The medical device and life sciences industries, where IPR is frequently used to challenge foundational patents, will find practical guidance in the court’s holistic approach to evaluating the adequacy of PTAB obviousness findings.